Petros Pharmaceuticals (PTPI) Financials

$0.01

$-0.04 (-83.12%)

As on 09-Sep-2026 15:21EDT

Market cap

$0 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

0

P/B Ratio

0.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	5.11	5.82	5.99	7.81
Cost of Revenue	--	--	1.21	1.63	2.29	1.60
Gross Profit	--	--	3.90	4.19	3.70	6.21
Operating Expenses	3.40	4.64	21.58	17.81	23.62	24.26
Operating Profit (EBIT)	-3.40	-4.64	-17.68	-13.62	-19.92	-18.05
Other Income	--	--	--	--	--	--
Profit before Tax	-3.20	-4.50	-14.32	-8.16	-20.04	-8.99
Provision for Tax	-6,413.64	-6,413.64	26,782.84	5,651.21	7.00	0.37
Profit after Tax (Net Income)	-3.20	1.91	-14.32	-8.16	-20.04	-8.99
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-8.99

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	0.70	2.87	-7.47	12.48	16.70	35.54
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	0.08	10.55	8.65	0.87
Current Liabilities	2.84	2.29	18.03	10.77	7.07	30.98
Total Liabilities	6.39	5.16	10.64	33.80	32.42	67.39

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	--	--	3.34	13.41	17.75	36.85
Current Assets	3.55	5.16	7.29	20.39	14.67	30.54
Total Assets	7.09	5.16	10.64	33.80	32.42	67.39
Total Debt*	--	--	7.39	8.28	9.88	0.41
Net Current Assets	--	2.87	-10.73	9.62	7.60	-0.44

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-6.73	-2.60	-7.63	-12.80	-11.86
Cash Flow from Investing Activities	--	--	-0.02	--	--	--
Cash from Financing Activities	--	8.16	-7.00	11.54	-1.62	18.57
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.07	0.05	-1.78	-2.73	-9.65	-6.34
Cash EPS ($)	--	0.05	-1.42	-1.59	-6.96	-1.49
Adjusted Book Value ($)	--	0.07	--	4.17	8.05	25.07
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.16	-0.32	-2.55	-6.17	-8.37
Free Cash Flow per Share ($)	--	-0.16	-0.33	-2.55	-6.17	-8.37

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	137.20	-138.51	-34.49	-64.08	-29.35
ROE (%)	-179.29	-83.26	-571.33	-55.95	-76.70	-33.90
ROA (%)	-36.72	24.22	-64.45	-24.66	-40.15	-13.10
EBIT Margin (%)	--	--	-269.13	-131.00	-324.46	-110.33
Net Margin (%)	--	--	-280.10	-140.20	-334.40	-115.05
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	-1.00	-0.12	-0.03	-0.23	-0.18
EBIT Growth (%)	-29,175.98	--	-80.38	60.77	-125.59	54.55
Net Profit Growth (%)	61.52	113.36	-75.41	59.26	-122.97	56.35
EPS Growth (%)	97.71	1.03	0.35	0.72	-0.52	0.66
Book Value Growth (%)	-91.38	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	0.00	--	-0.22	-0.52	-0.24	-0.53
Price / Book Value	0.30	--	-0.42	0.34	0.29	0.13
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.15	--	342.09	0.20	-0.39	10.76
Close Price ($)	--	--	9.85	35.25	58.25	832.50
High Price ($)	--	--	56.75	238.50	905.00	1,300.00
Low Price ($)	--	--	5.52	22.93	47.75	297.50
Market Cap ($ Cr)	0.25	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	--	-0.99	0.66	0.59	0.01
Short term debt to equity ratio	--	--	-0.98	0.10	0.07	0.00
Current Ratio	1.25	2.25	0.40	1.89	2.08	0.99
Quick Ratio	1.25	--	0.24	1.74	1.82	0.97
Interest Coverage	--	--	-24.53	-14.23	-32.62	-23.38

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	8.14	38.23	35.22	39.23
Asset Turnover	--	--	0.23	0.18	0.12	0.11
Receivable days	--	--	94.39	136.02	157.71	192.12
Inventory Days	--	--	694.15	383.51	186.24	146.16
Payable days	--	--	608.73	394.05	507.68	1,160.84
Cash Conversion Cycle	--	--	179.81	125.47	-163.72	-822.56

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.